论文部分内容阅读
目的分析局限晚期宫颈癌应用新辅助化疗联合放疗治疗的效果。方法随机选择2012年8月至2014年2月在本院接受治疗的局限晚期宫颈癌患者60例参与研究,随机平均分成2组,对照组选择单纯放疗治疗,观察组选择新辅助化疗联合放疗治疗,比较两组治疗效果。结果观察组治疗有效率为70%,对照组为56.7%;观察组2年内生存率为92.33%,对照组为80%;观察组不良反应发生率为26.67%,对照组为30%;观察组治疗后肿瘤直径为(1.84±1.16)cm,对照组为(2.96±1.38)cm。结论新辅助化疗联合放疗治疗局限晚期宫颈癌效果较单纯应用放疗治疗的效果更为明显,值得推广。
Objective To analyze the effect of neoadjuvant chemotherapy combined with radiotherapy in the treatment of advanced cervical cancer. Methods A total of 60 patients with locally advanced cervical cancer who were treated in our hospital from August 2012 to February 2014 were randomly divided into two groups. The control group was treated with radiotherapy alone. The observation group was treated with neoadjuvant chemotherapy plus radiotherapy , Comparing the treatment effect of two groups. Results The effective rate of the observation group was 70% and that of the control group was 56.7%. The 2-year survival rate was 92.33% in the observation group and 80% in the control group. The incidence of adverse reactions in the observation group was 26.67% and that in the control group was 30% The diameter of the tumor was (1.84 ± 1.16) cm after treatment and (2.96 ± 1.38) cm in the control group. Conclusion Neoadjuvant chemotherapy combined with radiotherapy for the treatment of locally advanced cervical cancer is more effective than radiotherapy alone and is worth promoting.